Innovative Testing Solutions 3EO Health offers cutting-edge molecular diagnostic tools that enable rapid, point-of-care testing, including FDA EUA-approved over-the-counter COVID-19 tests. This positions the company to serve healthcare providers, pharmacies, and community health organizations seeking quick, reliable testing options.

Recent Recognition & Funding The company recently received a $6 million NIH radx award and FDA Emergency Use Authorization, demonstrating strong institutional support and regulatory validation that can be leveraged to expand sales and foster trust with new clients and partners.

Expanding Access to Care 3EO’s mission to bring molecular testing beyond traditional settings into homes, work, and community environments creates opportunities in telehealth, home care, and local clinics, appealing to organizations aiming to enhance patient engagement and care accessibility.

Growth Potential in Diagnostics With a revenue range estimated between 1 million and 10 million and recent product launches, there is significant upside for partnerships with health systems, public health agencies, and private providers looking to incorporate innovative, cost-effective testing mechanisms.

Tech-Driven Advantage Utilizing a robust tech stack including cloud storage, analytics, and security solutions, 3EO Health's digital infrastructure supports scalable deployment and data management, appealing to organizations prioritizing integrated, tech-enabled health solutions.